Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element

Archive ouverte

Baxter, Joseph S | Johnson, Nichola | Tomczyk, Katarzyna | Gillespie, Andrea | Maguire, Sarah | Brough, Rachel | Fachal, Laura | Michailidou, Kyriaki | Bolla, Manjeet K | Wang, Qin | Dennis, Joe | Ahearn, Thomas U | Andrulis, Irene L | Anton-Culver, Hoda | Antonenkova, Natalia N | Arndt, Volker | Aronson, Kristan J | Augustinsson, Annelie | Becher, Heiko | Beckmann, Matthias W | Behrens, Sabine | Benitez, Javier | Bermisheva, Marina | Bogdanova, Natalia V | Bojesen, Stig E | Brenner, Hermann | Brucker, Sara Y | Cai, Qiuyin | Campa, Daniele | Canzian, Federico | Castelao, Jose E | Chan, Tsun L | Chang-Claude, Jenny | Chanock, Stephen J | Chenevix-Trench, Georgia | Choi, Ji-Yeob | Clarke, Christine L | Colonna, Sarah | Conroy, Don M | Couch, Fergus J | Cox, Angela | Cross, Simon S | Czene, Kamila | Daly, Mary B | Devilee, Peter | Dörk, Thilo | Dossus, Laure | Dwek, Miriam | Eccles, Diana M | Ekici, Arif B | Eliassen, a Heather | Engel, Christoph | Fasching, Peter A | Figueroa, Jonine | Flyger, Henrik | Gago-Dominguez, Manuela | Gao, Chi | García-Closas, Montserrat | García-Sáenz, José A | Ghoussaini, Maya | Giles, Graham G | Goldberg, Mark S | González-Neira, Anna | Guénel, Pascal | Gündert, Melanie | Haeberle, Lothar | Hahnen, Eric | Haiman, Christopher A | Hall, Per | Hamann, Ute | Hartman, Mikael | Hatse, Sigrid | Hauke, Jan | Hollestelle, Antoinette | Hoppe, Reiner | Hopper, John L | Hou, Ming-Feng | Ito, Hidemi | Iwasaki, Motoki | Jager, Agnes | Jakubowska, Anna | Janni, Wolfgang | John, Esther M | Joseph, Vijai | Jung, Audrey | Kaaks, Rudolf | Kang, Daehee | Keeman, Renske | Khusnutdinova, Elza | Kim, Sung-Won | Kosma, Veli-Matti | Kraft, Peter | Kristensen, Vessela N | Kubelka-Sabit, Katerina | Kurian, Allison W | Kwong, Ava | Lacey, James V | Lambrechts, Diether | Larson, Nicole L | Larsson, Susanna C | Le Marchand, Loic | Lejbkowicz, Flavio | Li, Jingmei | Long, Jirong | Lophatananon, Artitaya | Lubiński, Jan | Mannermaa, Arto | Manoochehri, Mehdi | Manoukian, Siranoush | Margolin, Sara | Matsuo, Keitaro | Mavroudis, Dimitrios | Mayes, Rebecca | Menon, Usha | Milne, Roger L | Mohd Taib, Nur Aishah | Muir, Kenneth | Muranen, Taru A | Murphy, Rachel A | Nevanlinna, Heli | O'Brien, Katie M | Offit, Kenneth | Olson, Janet E | Olsson, Håkan | Park, Sue K | Park-Simon, Tjoung-Won | Patel, Alpa V | Peterlongo, Paolo | Peto, Julian | Plaseska-Karanfilska, Dijana | Presneau, Nadege | Pylkäs, Katri | Rack, Brigitte | Rennert, Gad | Romero, Atocha | Ruebner, Matthias | Rüdiger, Thomas | Saloustros, Emmanouil | Sandler, Dale P | Sawyer, Elinor J | Schmidt, Marjanka K | Schmutzler, Rita K | Schneeweiss, Andreas | Schoemaker, Minouk J | Shah, Mitul | Shen, Chen-Yang | Shu, Xiao-Ou | Simard, Jacques | Southey, Melissa C | Stone, Jennifer | Surowy, Harald | Swerdlow, Anthony J | Tamimi, Rulla M | Tapper, William J | Taylor, Jack A | Teo, Soo Hwang | Teras, Lauren R | Terry, Mary Beth | Toland, Amanda E | Tomlinson, Ian | Truong, Thérèse | Tseng, Chiu-Chen | Untch, Michael | Vachon, Celine M | van den Ouweland, Ans M W | Wang, Sophia S | Weinberg, Clarice R | Wendt, Camilla | Winham, Stacey J | Winqvist, Robert | Wolk, Alicja | Wu, Anna H | Yamaji, Taiki | Zheng, Wei | Ziogas, Argyrios | Pharoah, Paul D P | Dunning, Alison M | Easton, Douglas F | Pettitt, Stephen J | Lord, Christopher J | Haider, Syed | Orr, Nick | Fletcher, Olivia

Edité par CCSD ; Elsevier (Cell Press) -

International audience. A combination of genetic and functional approaches has identified three independent breast cancer risk loci at 2q35. A recent fine-scale mapping analysis to refine these associations resulted in 1 (signal 1), 5 (signal 2), and 42 (signal 3) credible causal variants at these loci. We used publicly available in silico DNase I and ChIP-seq data with in vitro reporter gene and CRISPR assays to annotate signals 2 and 3. We identified putative regulatory elements that enhanced cell-type-specific transcription from the IGFBP5 promoter at both signals (30- to 40-fold increased expression by the putative regulatory element at signal 2, 2- to 3-fold by the putative regulatory element at signal 3). We further identified one of the five credible causal variants at signal 2, a 1.4 kb deletion (esv3594306), as the likely causal variant; the deletion allele of this variant was associated with an average additional increase in IGFBP5 expression of 1.3-fold (MCF-7) and 2.2-fold (T-47D). We propose a model in which the deletion allele of esv3594306 juxtaposes two transcription factor binding regions (annotated by estrogen receptor alpha ChIP-seq peaks) to generate a single extended regulatory element. This regulatory element increases cell-type-specific expression of the tumor suppressor gene IGFBP5 and, thereby, reduces risk of estrogen receptor-positive breast cancer (odds ratio = 0.77, 95% CI 0.74-0.81, p = 3.1 × 10-31). Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Suggestions

Du même auteur

Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk

Archive ouverte | Liu, Jingjing | CCSD

International audience. In breast cancer, high levels of homeobox protein Hox-B13 (HOXB13) have been associated with disease progression of ER-positive breast cancer patients and resistance to tamoxifen treatment. S...

Rare germline copy number variants (CNVs) and breast cancer risk

Archive ouverte | Dennis, Joe | CCSD

International audience. Germline copy number variants (CNVs) are pervasive in the human genome but potential disease associations with rare CNVs have not been comprehensively assessed in large datasets. We analysed ...

Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

Archive ouverte | Michailidou, Kyriaki | CCSD

International audience. Genome-wide association studies (GWAS) and large-scale replication studies have identified common variants in 79 loci associated with breast cancer, explaining ∼14% of the familial risk of th...

Chargement des enrichissements...